دورية أكاديمية
Cell and gene therapy accessibility.
| العنوان: | Cell and gene therapy accessibility. |
|---|---|
| المؤلفون: | Rouce RH; Rayne H. Rouce is an associate professor at the Center for Cell and Gene Therapy, Dan L. Duncan Comprehensive Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA., Porteus MH; Matthew H. Porteus is a professor in the Department of Pediatrics and the Center for Definitive and Curative Medicine, Stanford University School of Medicine, Stanford, CA, USA. |
| المصدر: | Science (New York, N.Y.) [Science] 2024 Aug 02; Vol. 385 (6708), pp. 475. Date of Electronic Publication: 2024 Aug 01. |
| نوع المنشور: | Editorial; Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Original Publication: New York, N.Y. : [s.n.] 1880- |
| مواضيع طبية MeSH: | Cell- and Tissue-Based Therapy*/economics , Genetic Therapy*/economics , Health Services Accessibility*, Humans ; Anemia, Sickle Cell/therapy ; Anemia, Sickle Cell/genetics ; Neoplasms/therapy ; Neoplasms/genetics ; Cost-Benefit Analysis |
| مستخلص: | Patients with devastating illnesses demonstrate incredible courage in battling their disease. Innovative cell and gene therapies (CGTs), built on decades of research, are changing the lives of those who suffer from conditions ranging from cancer to sickle cell disease to neurologic diseases. Although hailed for their promise and recognized for benefits that will exceed the costs, the high prices of CGTs ($300 thousand to $4 million per dose) leave these therapies out of reach for many. This accessibility problem will only be solved if academia, industry, investors, funders, regulators, and advocacy groups work together to put CGT breakthroughs in the hands of all who stand to benefit. |
| تواريخ الأحداث: | Date Created: 20240801 Date Completed: 20240801 Latest Revision: 20240802 |
| رمز التحديث: | 20240803 |
| DOI: | 10.1126/science.ads0252 |
| PMID: | 39088615 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1095-9203 |
|---|---|
| DOI: | 10.1126/science.ads0252 |